Stop the Bleeding – FDA Approves Praxbind® – Reversal Agent for Pradaxa®

Stop the Bleeding – FDA Approves Praxbind® – Reversal Agent for Pradaxa®

by John Kirtley, III | April 7th, 2016

Pradaxa® is an anticoagulant drug used for the prevention of stroke, blood clots in patients who undergo total hip replacement surgery or total knee replacement surgery, treatment of deep vein thrombosis and pulmonary embolisms, and the prevention of recurrence of such events in adults. Clinical use of Pradaxa equates to over four million patient-years in